Conray 43

   
Google
 
Web NewDrugInformation.com

Conray 43


Drug - Conray 43
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Iothalamate Meglumine
Multiple ingredients are in alphabetical order.

Strength - 43%
The potency of the active ingredient(s), Iothalamate Meglumine. May repeat for multiple part products.

Applicant - MALLINCKRODT
The firm name holding legal responsibility for Conray 43. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 013295
The FDA assigned number to Conray 43. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Conray 43. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Conray 43 was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Conray 43. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Conray 43 is in. Format is RX, OTC, DISCN.

Applicant Full Name - Mallinckrodt Medical Inc
The full name of the firm holding legal responsibility for the new application of Conray 43.

Conray 43